AstraZeneca PLC (AZN) News Headlines

▮ More

Date

Headline

3/26/2020 3:13:42 AM AstraZeneca Reports Approval Of Lokelma In Japan For Treatment Of Hyperkalaemia

3/26/2020 3:04:16 AM AstraZeneca Says Lokelma Approved In Japan For The Treatment Of Hyperkalaemia

3/25/2020 7:22:08 AM Silence Therapeutics Enters Collaboration With AstraZeneca

3/19/2020 4:03:03 AM AstraZeneca: Lynparza Gets Orphan Drug Designation In Japan

3/19/2020 3:07:58 AM AstraZeneca Says Lynparza Granted Orphan Drug Designation In Japan

3/17/2020 4:18:00 AM AstraZeneca's Late-stage Lung Cancer Trial Fails To Meet Primary Endpoint

3/17/2020 3:04:42 AM AstraZeneca Reports Results From Final Analysis Of Phase III CASPIAN Trial

3/12/2020 4:07:51 AM AZN : Late-stage Trial On Ovarian Cancer Fails To Meet Primary Endpoint Of PFS

3/12/2020 3:20:39 AM AstraZeneca Says Phase III GY004 Trial Did Not Meet Primary Endpoint

3/6/2020 2:17:00 AM AstraZeneca: DANUBE Trial For Imfinzi, Tremelimumab Fails To Meet Endpoints

3/6/2020 2:04:55 AM AstraZeneca Says Phase III DANUBE Trial Did Not Meet Primary Endpoints

3/3/2020 8:08:41 AM AbbVie And Allergan: European Commission Approve Divestiture Of Brazikumab To AstraZeneca

3/2/2020 2:04:13 AM AstraZeneca Completes Divestment Agreement With Atnahs Pharma

3/2/2020 12:26:00 AM Biotech Stocks Facing FDA Decision In March 2020

2/25/2020 2:47:39 AM AstraZeneca To Sublicense Worldwide Rights To Movantik To RedHill Biopharma

2/25/2020 2:06:49 AM AstraZeneca Agrees To Sublicense Global Rights To Movantik To RedHill Biopharma

2/14/2020 2:28:18 AM AstraZeneca FY19 Core Operating Profit Rises; Sales Up 12% - Quick Facts

2/14/2020 2:01:52 AM AstraZeneca Q4 Reported EPS $0.24; Core EPS $0.89

1/28/2020 8:19:25 AM Long-term Stocks To Watch: AstraZeneca PLC (AZN)

1/27/2020 2:35:54 AM AstraZeneca: Brilinta, Enhertu Met Primary Endpoint In Respective Trials

Astrazeneca Plc (AZN)